Identifying such markers could facilitate the early detection of cerebral microvasculature changes and improve our understanding of APOE’s role in AD pathophysiology, develop biomarkers for early diagnosis, and provide therapeutic targets for early intervention. Here, APOE is linked to Alzheimer disease.